361例主髂动脉闭塞症外科治疗的临床疗效分析

Analysis of clinical effects of surgical treatment for aortoiliac occlusive disease:a report of 361 cases

目的分析主髂动脉闭塞症(aortoiliac occlusive disease,AIOD)外科治疗的疗效。方法回顾性分析首都医科大学宣武医院2017~2021年外科治疗的361例AIOD患者的临床资料和疗效。结果357例患者取得技术成功,技术成功率为98.89%。337例患者(93.35%)症状得到改善。围术期11例患者(3.05%)出现并发症,2例患者(0.55%)死亡。患者平均随访(22.74±16.18)个月,术后6、12和36个月的总体一期通畅率分别为98.87%、97.58%和83.18%,术后12个月和36个月免于靶血管重建率分别为99.01%和91.67%。结论外科治疗AIOD的并发症发生率和死亡率较低,短中期通畅率满意;所有类型的AIOD患者均可尝试首选使用腔内治疗。

Objective To analyze the clinical effects of surgical treatment for aortoiliac occlusive disease(AIOD).Methods The clinical data and clinical effects of 361 patients with AIOD who received surgical treatment in Xuanwu Hospital,Capital Medical University between 2017 and 2021 were analyzed retrospectively.Results Surgical treatment were successfully performed in 357 patients,and the technical success rate of 98.89%.Symptoms improved in 337 patients(93.35%).Complications occurred in 11 patients(3.05%),and 2 patients(0.55%)died in the perioperative period.The patients were followed up for an average of(22.74±16.18)months.The overall primary patency rates were 98.87%,97.58%and 83.18%at 6,12 and 36 months after surgery,respectively,and the rates of freedom from target lesion revascularization at 12 and 36 months after surgery were 99.01%and 91.67%,respectively.Conclusion Surgical treatment of AIOD has lower morbidity and mortality,and satisfactory short-and mid-term patency rates.Endovascular treatment could be the first choice for all types of AIOD patients.